This article explores the growth of the Glycopyrronium Bromide API...

σε πρόσθεσε στο Health

2026-08-24 13:15:15 - Μετάφραση -

This article explores the growth of the Glycopyrronium Bromide API Market, driven by the rising prevalence of respiratory diseases like COPD, advancements in drug formulation, and the expanding generic API sector.

Chronic respiratory diseases, including Chronic Obstructive Pulmonary Disease (COPD) and asthma, represent a significant and growing global health burden. At the heart of effective treatments for these conditions are active pharmaceutical ingredients (APIs) like Glycopyrronium Bromide, a potent anticholinergic bronchodilator. The Glycopyrronium Bromide API Market, valued at USD 300 Million in...

0 Σχόλια 0 Μοιράστηκε 119 Views 0 Προεπισκόπηση